A wind of change is blowing at Johnson & Johnson MedTech with the unexpected announcement of the departure of its CIO, Larry Jones. After 35 years of commitment and significant achievements within this cutting-edge company, Jones reflects on a new chapter in his professional life, leaving behind a legacy marked by digital transformation bold and innovations that have redefined the landscape of medical devices. The echoes of his farewell resonate across the industry, conjuring a reflection on the impact of his journey.

Larry Jones, the global director of information technology at Johnson & Johnson MedTech, announces his departure after 35 years within the company. On LinkedIn, he shares memories of his journey and expresses his gratitude to his colleagues, while affirming that it is not a goodbye, but a “see you soon”. His last day of work is scheduled for November 15. Jones played an integral role in the digital transformation of the company, which generates more than $30 billion in annual sales, making it one of the largest medical device manufacturers in the world.

The unexpected departure of Larry Jones

Larry Jones, THE CIO of Johnson & Johnson MedTech, recently announced his departure after an impressive career of 35 years old within this emblematic company. In a message shared on LinkedIn, he expressed his thoughts on the challenges and triumphs he encountered during his time in the medical device industry. This departure, although expected by some due to restructuring in the company, surprised many others who considered him a pillar of the success of J&J MedTech.

A major contribution to digital transformation

Jones played a central role in the digital transformation of Johnson & Johnson, accentuating the importance of technological innovation in the healthcare sector. His departure marks the end of an era, leaving behind a legacy of initiatives that have propelled the company into the future. During his years, he also oversaw major projects, including a large transformation program worth 200 million dollars aimed at improving business processes and integrating solutions based on cloud.

The new management of Johnson & Johnson MedTech

At a time when Johnson & Johnson is focused on the future, the question of Jones’ succession arises. Although the leadership model is evolving, the company continues to focus on innovative solutions to face challenges. global health challenges. THE leadership and the skills that Jones offered will be difficult to replace, but his contributions to the corporate culture and team spirit will remain an asset for the future direction that will take J&J MedTech.